Try our Advanced Search for more refined results
Life Sciences - November, 2021
298 articles
- NY Says Amazon Should Be Forced To Address COVID Safety
- High Court's Right Flank Floats Chevron Deference Overhaul
- Jury Says BGI Owes Illumina $8M For Infringing DNA Patents
- 'God's Tigress': Feds Query Holmes On Balwani 'Love' Texts
- Biden Vax Mandate Preliminarily Blocked By La. Federal Judge
- FDA Panel Backs Merck COVID Pill For High-Risk Adults
- Split Fed. Circ. Upholds Mylan's Win In Axing Tecfidera Patent
- Behind The Scenes With Opioid Attys At Landmark Jury Trial
- IP Challengers Lose Invalidation Bids After '101 Day' Fight
- Meet The Attys Battling Over The Future Of Abortion Rights
- 11th Circ. Sends Drug Effect Questions To Ala. High Court
- BCLP Partner Jumps To Perkins Coie In DC
- Nevada Pot Shop Faces $487K Fine, Ban Over Stolen Plants
- Med Device Case Highlights Physician IP Deal Best Practices
- Judge Blocks Biden's Contractor Vax Mandate In 3 States
- Judge Says Attys For Biotech Whistleblower Should Get $6M
- Ex-OSI Controller Gets 3 Years For Insider Trading Conviction
- Without Leadership Buy-In, Law Firm DEI Efforts Stand To Fail
- Holmes Says Ex-Theranos Exec Controlled And Abused Her
- J&J's Bankruptcy Move To NJ Cracks Door For Dismissal Bid
- Catalent Can't Duck IP Suit Over Epilepsy Drug Vimpat
- WTO Delays Talks Over IP Waiver Amid New Variant Concerns
- Mallinckrodt Gets Ch. 11 Stay Of Acthar Suits Extended
- CBD Company Slammed With ADA Suit Over Website Access
- Biofrontera Settles Skin Therapy IP Suit On Eve Of Trial
- Patent Eligibility Is Becoming Increasingly Relevant At ITC
- Confronting Origination Credit: Self-Advocacy Tips For Attys
- Big Names Could Stack December's IPO Pipeline
- Hagens Berman Stalling Thalidomide Suits Probe, Clients Say
- Fed. Circ. Affirms PTAB Ax Of Indivior's Suboxone Patent
- As ANDA Suit Venue Options Shrink, Del., NJ Rule For Now
- GOP Lawmakers Urge Tai To Oppose COVID Vaccine IP Waiver
- Ga. Justices Won't Review Ruling That Talc Claims Were Late
- Surgical Robot Co. Must Face Instruments Antitrust Claims
- High Court Delays Mulling Apple, Mylan Fintiv Challenges
- Westlake Pays $1.2B For Epoxy Biz Of Davis Polk-Led Hexion
- Rail Unions Say Amtrak's Vaccine Mandate Is Unlawful
- 7th Circ. Tosses Iraq War Vet's VA Suit As Duplication
- How 'Rocket Dockets' Are Affecting IPR Discretionary Denials
- Convicted Ex-Insys Execs Must Pay $48.3M To Victims
- Novartis Wants Atty DQ'd From MS Drug Patent Row In Del.
- A Real-World Guide To Staying Discovery In Federal Court
- Teva Attorneys Leave Goodwin Procter For Greenberg Traurig
- Pharma Biz Hits Back At Contractors In Contamination Row
- Holmes Admits Adding Pfizer Logo To Reports For Walgreens
- Despite Jury Win, Opioid Attys Predict 'A Long Way To Go'
- Pfizer Says Employee Stole Confidential Docs On COVID Vax
- Amgen Takes Antibody Patents Invalidation To Supreme Court
- Allergan Investors' Attys Claim $30.9M Of Price-Fixing Deal
- Fox Rothschild Nabs IP Partner With Pharma Background
- Ariz. Reaches $14.5M Settlement With Juul Over Youth Vaping
- Del. Chemical Plant Escapes Toxic Waste Suit, For Now
- Monsanto Tells Justices $25M Roundup Verdict Must Fall
- Lawmakers Urge Biden To Stand Firm On COVID IP Waiver
- Rutgers, College Of NJ Aim To Erase Vaccine Mandate Suits
- United Workers Can't Halt Vax Mandate Amid 5th Circ. Appeal
- Pharmacy Giants Fueled Opioid Crisis, Ohio Jury Finds
- Ranbaxy Can't Shake MDL Antitrust Claims As Trial Nears
- Illumina's Bid For $25M Over DNA Tech Patents Goes To Jury
- Sanofi Unit To Pay $180M In Disease Treatment Patent Fight
- Holmes Testifies She Thought Theranos Could Do 'Any Test'
- Fla. Co. Pleads Guilty To Conspiracy To Sell Illegal Products
- CORRECTED: PTAB Axes Patent After Purdue Ch. 11 Delay
- Judge Rejects Probe Of Asbestos Votes In Mallinckrodt Ch. 11
- DOJ-Walmart Opioid Battle Halted As High Court Reviews CSA
- J&J Talc Claimants Vow To End Unit's 'Bad Faith' Ch. 11 Case
- Pesticide Use Targeted In New Senate Farmworker Safety Bill
- Teva Says Mylan Is Just Unhappy About MS Drug Competition
- DL Unit's $2.5B Deal For Kraton Gets US Merger Approval
- Fla. Can't Block Federal Health Care Staff Vaccine Mandate
- Choosing The Right IP Protections For Telehealth Innovations
- Medical Cannabis Co. Akanda Files Confidential IPO Docs
- Convicted Illumina Insider Trader Loses $4.5M Forfeiture Fight
- Quest Diagnostics Fertility Biz Sued Over Data Breach
- Supreme Court Won't Review Kodak Injury Claims From Ch. 11
- Illumina Defends Validity Of DNA Sequencing Patents At Trial
- 3rd Circ. Sinks Heart Monitor Co.'s BCBS Antitrust Case
- Acthar Claimants Seek Mallinckrodt Chapter 11 Vote Probe
- Suzanne Somers Drops QVC Nutritional-Supplement Suit
- Texas Appeals Court OKs Temporary Block Of Delta-8 Ban
- Texas Judge Stands By Ruling In United Airlines Vaccine Fight
- Holmes Tells Jurors Some Investors Didn't Want Theranos Info
- FDA, CDC Panel Clear COVID Boosters For All Adults
- To Vax Or Not To Vax Is Not A Constitutional Question
- How To Draft Earnouts That Avoid Post-Closing Disputes
- Mitigating Inflation's Impact On Commercial Contracts
- Fla. Pharma Co. Brings Trade Secrets Suit Over Cancer Work
- Boston Scientific Investors Told To Get To Heart Of Stock Suit
- Health Hires: Baker Donelson, Proskauer
- Horse-Doping Vet Asks For No Prison With Life In 'Shambles'
- Sorrento Escapes COVID-19 Investor Class Action
- Insurance Tips For Mitigating DOJ Cyber Initiative Risks
- Businesses Appeal £100M CMA Fine For Overpriced Drug
- Fortune Writer Claims Holmes Duped Him As DOJ Wraps Case
- 3 Ex-US Officials Reject 'Willy-Nilly' Virus Vaccine IP Waivers
- IP Forecast: Delaware '101 Day' To Start Off With Natera Battle
- Calif. High Court Leaves $87M Roundup Verdict In Place
- Bayer, Amgen Unit Drop IP Suit Over Cancer Drug Generic
- Purdue Cleared To Pay Gov't Groups Over $12M In Ch. 11 Fees
- New Laws, Suit Step Up Fla. Fight Against Vaccine Mandates
- 'Robust' Process Picked Imerys Claims Rep, Trustee Says
- Hand Sanitizer Co. Settles $2.5M Suit Over Disinfectant Order
- Verrill Adds Lead Prosecutor On Insys Case To Boston Office
- Goodwin Lands Technology Expert From Foley
- NJ Firm Accused Of Overcharging Benicar MDL Clients
- M&A Rulings Provide Guidance On 'Bump-Up' Claim Coverage
- Mallinckrodt Ch. 11 Plan Hearing Won't Restart Monday
- 3 Firms Lead Novo Nordisk's $3.3B Dicerna Buy
- 'Laws Of Chemistry' Trump PTAB, Illumina Rival Tells Jury
- Theranos Patient Got Incorrect HIV Test Result, Jury Told
- Biden Plans To Expand COVID-19 Vaccine Supply By 2022
- Mallinckrodt Denies Manipulating Acthar Market
- Drugmaker Says 11th Circ. Ruling Based On 'Straw Man'
- COVID 'Devastating' For Opioid Epidemic, Wash. Judge Told
- Pfizer's $2.3B Trillium Deal Closes Without FTC Challenge
- Ohio Counties Deride Pharmacies' Opioid Mistrial Bid
- Consumer Counsel Gets $115M From EpiPen Settlement
- $600K For Atty Fees Awarded In Pot Co. Investor Settlement
- Heed These Rules, Or Risk Your Argument On Appeal
- Texas Hospital Workers Fight Vaccine Mandate At 5th Circ.
- Teva Says Dr. Reddy's Broke Deal Over Birth Control Device
- 9th Circ. Backs Removal Order Over Animal Abuse
- Skadden's Allison Brown On J&J's Talc Trial Win In Mo.
- It May Be Time To Abolish Patent Claim Construction Hearings
- Teva, Cooper Cos. Must Face All Claims In Paragard IUD MDL
- Unvaxxed Athletes Settle Religious Claims Against College
- Convicted Insider Trader Must Disclose Atty Communications
- Investors Gave Theranos $96M Despite Due Diligence Gaps
- Michigan Town Ducks Weed Growers' Pot Raid Suit
- Merck, Glenmark Want Jury To Decide Zetia Antitrust Market
- Pharmacies Urge Mistrial In Opioid Case As Jury Deliberates
- Purdue Claimants Say Ch. 11 Appeals Threaten Recoveries
- Medical Device Co. To Pay $10M To End Suit Over Stock Drop
- Pfizer Wants FDA Emergency Approval For COVID Treatment
- Pfizer Must Face Trimmed Robitussin Labeling Suit
- Whistleblowers Defend FCA Suit Against HIG Capital
- FTC Tells High Court Impax Ruling Needs No Review
- What To Include In Orders Governing Remote Arbitration
- Mallinckrodt Says Insurers' Acthar Claims Off By $317M
- NC AG Investigating Puff Bar Over Youth E-Cig Sales
- Fed. Circ. Clears Alkem In Horizon Painkiller IP Row
- Ex-DOD GC Rejoins Wilson Sonsini In Calif.
- Kirkland & Ellis Nabs Environmental Atty From Doughty
- Theranos Investor FOMO Is Due Diligence Lesson, Attys Say
- 3rd Circ. Vexed By Timing Of Cancer Lab's RICO Suit
- Law Firms Plant Feet In DC As Regulatory, IP Landscape Shifts
- Wash. AG Steals Defense Thunder As $95B Opioid Trial Starts
- Lax Pharmacies Fed Opioid Crisis, Jury Told As Trial Ends
- Theranos Investor Emailed Prosecutors During Trial, Jury Told
- Illumina Tells Jury BGI Copied Its DNA Sequencing Patents
- Fla. Judge Denies Injunction Against DOD Vax Mandate
- FDA Scraps Trump-Era Leeway For Lab Test Authorizations
- Mallinckrodt Exec Says Acthar Price Hikes Were Necessary
- Texas Oil Driller Escapes Liability In Rig Worker's Stroke Suit
- 6th Circ. Backs FDA, Won't Let Co.'s E-Cigs Back On Market
- Village Farms Intl. Buys Majority Stake In Quebec Pot Grower
- 9th Circ. Sides With Anthem In Health Coverage Battle
- High Court Won't Hear Breast Implant Suits Against J&J Unit
- Embracing ESG: CBRE GC Talks Effective Compliance Emails
- Imerys Judge Won't OK Mediation Without Clear Rules
- Philips Claims Order A Hurdle To Fixing Sleep Apnea Devices
- Supreme Court Declines To Enter Flanax TM Fight
- Ginkgo Says Milbank Probe Rebuts Short-Seller's Fraud Claim
- Sen. Leahy Announces End To Congressional Career
- 5 Key Details As Drama Surrounds $95B Opioid Trial In Wash.
- EU's Expansion Of Merger Review Authority Poses Catch-22
- Illumina's DNA Patent Dispute With BGI Gets Calif. Jury
- Sanofi Beats Whistleblower Suit From Ex-Sales Reps
- Insurers Say Mallinckrodt Sales Strategy Cost Them $320M
- Convicted Illumina Insider Trader Fights $4.5M Forfeiture
- 7th Circ. Again Asked To Revive Becton Buyers' Antitrust Suit
- 9th Circ. Jurisdiction Ruling Guides On Class Action Strategy
- Amgen Backs Juno's Fed. Circ. Bid To Revive $1.1B Judgment
- United Workers Say Judge Overlooked Harms In Vaccine Fight
- The Hazards Of Female Lawyers Being 'Office Moms'
- J&J's Win In Opioid Health Insurance Class Action Is Affirmed
- 7th Circ. Nixes $8M Verdict In Ex-Prisoner's Med Mal Suit
- Biden Taps Ex-FDA Boss Califf To Lead Agency Again
- Cravath, Baker McKenzie-Led J&J Plans Consumer Biz Spinoff
- $626M Flint Water Deal OK'd, $202M Atty Fee Addressed Later
- Theranos Exec Threatened Investor With Litigation, Jury Told
- United Therapeutics Beats HHS' Discount-Dodging Claims
- Judge Says Patent Fight Over Herbicides Must Be Arbitrated
- FTC Judge Says Amici Offer Nothing New In Illumina Case
- Overdose Reversal Drug Maker Settles FCA Suit For $12.7M
- Fed. Circ. Orders Albright To Transfer Another Patent Case
- FTC Orders 2 Generics Divested In $210M Pharma Deal
- Opioid Litigation's Pillar Theory Is Suddenly Showing Cracks
- Discovery Immunity For Draft Expert Reports Lacks Clarity
- J&J Talc Liability Unit's Ch. 11 Transferred To NJ
- Eon, Sandoz Escape Claims Over Generic Heart Drug
- Paul Weiss Helps General Atlantic Snag $7.8B For Latest Fund
- Fed. Circ. Upholds Roche's Win In Cancer Therapy IP Review
- Arnold & Porter Names New Int'l Arbitration Co-Chair
- Ex-Theranos Lab Chief Doubted Holmes' 'Implausible' Takes
- Freezer Maker Can't Get Redo Of $15M Verdict Over Embryos
- Attys Want $1.8M Cut Of $3M ADHD Antitrust Settlement
- Purdue Agrees Not To Finalize Ch. 11 Plan Until Appeals Done
- Texas Judge Temporarily Blocks State's Delta-8 Ban
- A Phased Approach To In-House Legal Tech Adoption
- Okla. High Court Overturns J&J's $465M Opioid Defeat
- United Workers Can't Ground Airline's Vaccine Mandate
- Fertility Lab Sued Over Switched-Embryo 'Nightmare'
- Sanofi, Whistleblower Settle 19-Year Cancer Drug FCA Battle
- 8th Circ. Won't Block Feds' Kidney Transplant Reform
- High Court Won't Hear Breast Implant Suit Against J&J Unit
- Insurers Claim Mallinckrodt Inflated Acthar Price By $300M
- Mich. Appeals Court Upholds Suspension For Pot Doctor
- Coloplast Inks $2.5B Med Biz Deal With Linklaters-Led PE Firm
- Eye Clinic Can't Avoid Whistleblowers' Kickback Claims
- Qiagen Agrees To Pay $53M To Settle Patent Suit
- What To Watch As USTR Considers Chinese Tariff Exclusions
- DOJ Claims Texas Pharmacy Co. Inflated Ingredient Pricing
- 'Flanax' TM Case Could Bring High Court Clarity On 2 Issues
- Fla. Man Admits To $1M Genetic Testing Kickback Scheme
- Confronting Origination Credit: How Firms Can Redo Policies
- Shkreli's Old Co. Fair Game For Antitrust Trial, Judge Says
- J&J's Ch. 11 Talc Stay Deferred Until Case Venue Is Decided
- 4 BigLaw Players In Elizabeth Holmes' Criminal Fraud Trial
- NJ Judge Pauses Sanctions For Discount-Dodging Drug Cos.
- 2 Sun Pharma US Units To Pay $85M In Generic Drugs MDL
- Bristol-Myers Inks $10M Deal To End Drug Antitrust Claims
- 3rd Circ. Preview: Gun Ad Probe, 'Joke' Tweet Mark November
- Fed. Circ. Won't Let Celgene Challenge Mylan's Generic In NJ
- ITC To Probe Imports Of Cannabis Oil-Vaping Products
- EV Truck Maker Rivian's Potential $9.9B IPO Tops Deep Lineup
- Mallinckrodt Cleared On $94M Ch. 11 Bond Penalty
- J&J Unit's Ch. 11 Committee Approved Over Venue Concerns
- Dental Co. Sues Competitor Over Claims Of Effectiveness
- Ill. Plasma Center Reaches $9.9M Deal To End BIPA Suit
- How To Comply With ABA's New Language Access Guidance
- US Supreme Court To Hear Ala. 'Pill Mill' Conviction Case
- Cancer Patient Urges High Court To Ignore Monsanto Appeal
- UK Litigation Roundup: Here's What You Missed In London
- Hedge Fund Priest Beats SEC Short-And-Distort Claims
- Holmes Cited Walgreens Deal In Rushing Investors, Jury Told
- Cherokee Nation Bashes Pharmacies' Prescription Data Bid
- 6 More States Sue Biden Over Gov't Contractor Vax Mandate
- 5 Takeaways From Drugmakers' Win In Calif. Opioid Trial
- IP Forecast: Google Patent Fight Heads To Texas Jury
- WTO Warns Of Trade's Negative Impact On Climate Change
- Mallinckrodt Can Duck Acthar Royalties In Chapter 11
- FTC Questions Academics' Interest In Backing Illumina
- Jury Awards $1M To Medical Co.'s Buyer Over Soured Deal
- Shkreli Won't Take The Stand At FTC Antitrust Trial
- Kaiser Says Workers Rely On 'Bizarre' Theories In Vax Row
- Miss. AG Says J&J Using Justices' Time To Delay Talc Trial
- Texas Panel Won't End Fen-Phen Atty Malpractice Fight
- Fed. Circ. Revives Scottish University's MRSA Prevention IP
- Novartis Sells $20.7B Stake In Fellow Swiss Pharma Co. Roche
- Fecal Testing Startup Founders Can't Flush SEC Charges
- Boies Said Theranos Tech Was Sound, Investors' Atty Testifies
- Fertilizer Co. Gets Receiver To Help $7M Arbitration Collection
- J&J Unit Says Ch. 11 Stay Extension Needed To Handle Claims
- Novartis Fights Enhanced Damages Bid After $178M Jury Loss
- 3 Practice Tips For Patenting Medical Devices In A Digital Age
- Trader Who Profited From Illegal Illumina Tips Gets 3 Years
- Del. Justices Challenge Shire On $45M 'Windfall' Objection
- Invisalign Maker's $16M Investor Deal Gets Initial Nod
- Ark. Lab Owner Charged With $100M COVID-19 Fraud Scheme
- Best Practices For Hiring And Integrating Freelance Lawyers
- Priest Points Finger At Biotech As SEC Short Sale Trial Wraps
- Ex-Cravath Atty Introduced Rich Clients To Holmes, Jury Told
- CDC Recommends Pfizer Vaccine For Children Aged 5 To 11
- Walmart Tells 5th Circ. Its Pharmacists Are Stuck Over Opioids
- Antitrust Group Says Mallinckrodt Plan Lacks Sufficient Votes
- Teligent's Creditors Decry 'Skewed' Bankruptcy Financing
- How Hueston Hennigan Notched A Landmark Opioid Trial Win
- United Airlines Workers Want Class Cert. In Vax Mandate Suit
- Senators Pitch Pot Research Amendment To Defense Bill
- Generic-Drug Co. Wants Gout Drug Antitrust Suit Tossed
- Contractor Flipped Workout Machines On Amazon, Suit Says
- Buyers Win Backing For Narrow Market In Zetia Generic Suit
- J&J Unit Blasts Bid To Shield Marketing Info In Mesh Row
- Taiwanese Pharma Co. Can't Shake AOP Sanction Bid
- Illumina Says Convicted Insider Trader Broke Investors' Trust
- 5 Post-Theranos Insights On Board Member Oversight
- Pfizer Unit Agrees To Cover $69M Enviro Cleanup In NJ
- NorthShore Can't Dock Pay In Vax Mandate Row
- Arent Fox Settles Unpaid Legal Fees Dispute With Pharma Co.
- DuPont Buys Rogers Corp. In $5.2B Deal Led By 3 Firms
- Jury Awards Boston Scientific $20M In Nevro Patent Trial
- Rite Aid Settles With DOJ To Make Accessible Vaccine Sign-Up
- Drugmakers Not Liable For Calif. Opioid Crisis, Judge Finds
- IPO Market Could End 2021 With A Furious Finish
- Hirshfeld Won't Review Ax Of Arthrex Patent That Started It All
- COVID-19 Origins Inconclusive, US Intelligence Report Says
- Embracing ESG: Cognizant Counsel, CSO Talk Collaboration
- Chancery Tosses Chemours Stock Buyback, Dividend Suit
- Mallinckrodt Ch. 11 Hearing Starts With Valuation Questions
- Priest Urged Investors To 'Run' From Pharma Biz, Jury Hears
- Chicago Police Union Beats Vaccine Mandate — For Now
- Investor Sues Genetics Co. In Del. After Mystery Merger
- Faegre Drinker Adds Ex-Advarra Pharma Regulatory Adviser
- Justices Tackle 'Procedural Morass' In Texas Abortion Cases
- As Social Impact Becomes The Test, Firms Asked To Step Up
- The 2021 Law360 Pulse Social Impact Leaders
- Social Impact Leaders: A Look At Our New Law Firm Ranking